Deferred Tax Assets, Valuation Allowance of Maze Therapeutics, Inc. from 31 Dec 2024 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
- Summary
-
Maze Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
- Maze Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $112,030,000, a 27% increase year-over-year.
- Source SEC data
- View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)
Maze Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $112,030,000 | +$23,894,000 | +27% | 31 Dec 2025 | 10-K | 25 Mar 2026 | 2025 | FY |
| Q4 2024 | $88,136,000 | 31 Dec 2024 | 10-K | 25 Mar 2026 | 2025 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.